Amgen Inc. · Healthcare
$414.30
-0.7%
Aug 12, 2026
D
WeakGraded against AMGN's own history at this drawdown — not the market's.
What it means: AMGN's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of my
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: AMGN is 0.7% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
AMGN (Amgen) is 0.7% below its historical peak. Tape reads at or near all-time highs, with the last trade at $414.3. That puts AMGN in a momentum regime: buyers are in control and there's no meaningful technical damage on the chart yet.
AMGN reaches this drawdown band repeatedly in its history (2298 observations), which is a large sample for the segmentation engine to compute a stable median forward return. The engine uses a rolling 90-day window and gives more weight to recent years — this lets the signal adapt to regime changes (e.g., post-COVID volatility) without losing the long-run base rate.
S&P 500 names behave differently from small-caps at the same drawdown level — the Dipsern segmentation is per-ticker, so historical base rates for AMGN reflect its own volatility regime, not the market's. At this level the Dipsern signal is mostly tracking momentum, not mean reversion. Most buying-the-dip frameworks aren't relevant when there is no dip.
Five tickers closest to AMGN's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for AMGN. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of AMGN's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for AMGN.
Dipsern is research and a second opinion — not a broker. You'd buy AMGN at your own broker.
Analyze AMGN FreeNo credit card required · 5 free analyses per month
Signal computed Aug 12, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.